Study of AG10 in Amyloid Cardiomyopathy

Clinical trial NCT03458130 · COMPLETED

Trial details

NCT number: NCT03458130
Sponsor: Eidos Therapeutics, a BridgeBio company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Familial ATTR-CM (ATTRm-CM, or FAC)Wild-type ATTR-CM (ATTRwt-CM)

Start date: 2018-04-27
Primary completion: 2018-10-05
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.